Copyright
©The Author(s) 2020.
World J Clin Oncol. Mar 24, 2020; 11(3): 143-151
Published online Mar 24, 2020. doi: 10.5306/wjco.v11.i3.143
Published online Mar 24, 2020. doi: 10.5306/wjco.v11.i3.143
Figure 1 Kaplan-Meier survival curve comparing median overall survival between patients who had Pertuzumab treatment and who did not have Pertuzumab treatment.
- Citation: Rahardja S, Tan RYC, Sultana R, Leong FL, Lim EH. Efficacy, patterns of use and cost of Pertuzumab in the treatment of HER2+ metastatic breast cancer in Singapore: The National Cancer Centre Singapore experience. World J Clin Oncol 2020; 11(3): 143-151
- URL: https://www.wjgnet.com/2218-4333/full/v11/i3/143.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i3.143